Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 13 Issue: 3, March 2013

Editorial (Hot Topic: PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer)

Volume:13   Issue: 3
Pp: 233-233
Bing-Hua Jiang
DOI: 10.2174/1568009611313030001
Published on: 12 March, 2013

Diverse Mechanisms of AKT Pathway Activation in Human Malignancy

Volume:13   Issue: 3
Pp: 234-244
Mitchell Cheung and Joseph R. Testa
DOI: 10.2174/1568009611313030002
Published on: 12 March, 2013

Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer

Volume:13   Issue: 3
Pp: 245-251
Faton Agani and Bing-Hua Jiang
DOI: 10.2174/1568009611313030003
Published on: 12 March, 2013

Roles of EGFR, PI3K, AKT, and mTOR in Heavy Metal-Induced Cancer

Volume:13   Issue: 3
Pp: 252-266
Richard L. Carpenter and Bing-Hua Jiang
DOI: 10.2174/1568009611313030004
Published on: 12 March, 2013

Targeting the mTOR Pathway in Tumor Malignancy

Volume:13   Issue: 3
Pp: 267-277
Hengmiao Cheng, Marlena Walls, Sangita M. Baxi and Min-Jean Yin
DOI: 10.2174/1568009611313030005
Published on: 12 March, 2013

IDO+ DCs and Signalling Pathways

Volume:13   Issue: 3
Pp: 278-288
Yue Wang, Bao-Hong Yang, Hui Li, Shui Cao, Xiu-Bao Ren and Jin-Pu Yu
DOI: 10.2174/15680096113139990073
Published on: 12 March, 2013

Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma

Volume:13   Issue: 3
Pp: 289-299
Tatsuo Okui, Tsuyoshi Shimo, Takuya Fukazawa, Nur Mohammad Monsur Hassan, Tatsuki Honami, Soichiro Ibaragi, Munenori Takaoka, Yoshio Naomoto and Akira Sasaki
DOI: 10.2174/1568009611313030007
Published on: 12 March, 2013

Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma open access plus

Volume:13   Issue: 3
Pp: 300-312
Jordi Muntane, Angel J. De la Rosa, Fernando Docobo, Rocio Garcia-Carbonero and Francisco J. Padillo
DOI: 10.2174/15680096113139990075
Published on: 12 March, 2013

Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?

Volume:13   Issue: 3
Pp: 313-325
Matteo Santoni, Mimma Rizzo, Luciano Burattini, Rossana Berardi, Giacomo Carteni and Stefano Cascinu
DOI: 10.2174/1568009611313030009
Published on: 12 March, 2013

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives open access plus

Volume:13   Issue: 3
Pp: 326-346
Ziyad Binkhathlan and Afsaneh Lavasanifar
DOI: 10.2174/15680096113139990076
Published on: 12 March, 2013